摘要 |
<p>The present invention relates to uses of Macrolactin A produced by Bacillus polyfermenticus KJS-2 (KCCM 10769P), which is a new bacillus strain, as an antibiotic. Macrolactin A of the present invention, which is produced by Bacillus polyfermenticus KJS-2, shows a broad spectrum of antibiotic activity against a variety of microorganisms and fungi, and is proved to be very efficient for the inhibition of particularly vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA) that are multidrug-resistant bacteria. The antibiotic Macrolactin A produced by Bacillus polyfermenticus KJS-2, can be used as an excellent antibiotic against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA), and thus the present invention is a very useful invention for medical industry.</p> |
申请人 |
INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION;KANG, JAE-SEON;KIM, CHUN-GYU;KIM, DONG-HEE;KIM, KANG-MIN;KIM, DONG-HUN;LEE, JIN-YOUNG;CHOI, GUANG-JIN;CHA, IN-JUNE;HONG, JAE-SUN;HONG, YONG-GEUN |
发明人 |
KANG, JAE-SEON;KIM, CHUN-GYU;KIM, DONG-HEE;KIM, KANG-MIN;KIM, DONG-HUN;LEE, JIN-YOUNG;CHOI, GUANG-JIN;CHA, IN-JUNE;HONG, JAE-SUN;HONG, YONG-GEUN |